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A study has been carried out to assess the potential use ofpectin in combination with two
added hydrocolloids, i.e., hydroxy-propyl-methyl cellulose and hydroxyethyl cellulose in
varied concentrations and coated with ethyl cellulose and cellulose acetate phthalate. The
results ofin vitro drug release showedthat the matrix tabletsprepared with pectin, hydroxy
ethyl cellulose (20 percent) when coated with ethyl cellulose and cellulose acetate phtha-
late were found to be 63.0percent, 8.4percent, and4.5percent, respectively, in aftereight
hours during drug release study period. These results were confirmed with the results of
roentgenographic studies in nine healthyhuman volunteers to find the shape and integrity
ofthe dosage form. TheX-rayphotographs revealed thatthe enteric-coated tablet was vis-
ible only up to 5.5 hours and at the end ofeighth hour, the photograph has notshown any
presence of tablet indicating the loss ofshape and size by the microflora present in the
colon region. So, the results ofin vitro and roentgenographic studies revealed thatpectin,
hydroxy ethyl cellulose (20percent) base coated with ethyl cellulose and cellulose acetate
phthalate was found to be a promising carrierfornaproxen to colon.
INTRODUCTION
Adkin, Kenyon, et al. [1] studied the
use of scintiography as proof of concept
data in man using gamma scintiography
forcalcium pectinate preparations for drug
delivery to colon. Kenyon et al. [2] tested
the ability ofthe naturally occurring poly-
saccharide guar gum to deliver a corticos-
teroid, dexamethasone to colon using
pharmaco-scintography. Ashford et al.
[3], 1993, have demonstrated the lack of
site specificity of tablets in pH dependent
systems by using gamma, scintiographic
technique in healthy human volunteers.
Wilding et al. [4] have evaluated an
enteric-coated naproxen tablet formulation
using gamma scintiography in 12 healthy
male subjects. In recent past, an intense
interest has been elicited by different
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authors for finding out a suitable drug car-
rier material for colon targeting. Slany and
Mandak [5] studied the functional action
on citrous pectin in tablets on the dissolu-
tion of phenobarbital sodium and sodium
para-amino salicylic acid. They attributed
the retardation of dissolution rates due to
the formation of pectin hydrogel barrier.
Rubeinstein A et al. [6] studied chon-
droitin sulphate as potential biodegradable
carrier for a colon-specific drug delivery.
The same authors have evaluated calcium
pectinate as apotential colon drug delivery
carrier. Munjeri et al. [7] evaluated the
suitability of hydrogel beads based on
amylatedpectin forits potential use in film
forming polymers for colon drug delivery.
Turkoglu etal. [8] designed pectin hydrox-
ypropylmethyl cellulose matrix tablets to
find out their erosion property for colon
targeting. The above citations revealed
that pectin as a carrier for colon targeting
has not been fully explored. In 1999, Basit
et al. [9] reported and studied the use of
amylase coating as a means of delivering
drugs to the human colon. Amylase, a
high-molecular weight component of
starch can be digested by bacterial amy-
lase enzymes in the colon. Amylase, has
therefore, been applied as a coating, in
combination with water-insoluble poly-
merethyl cellulose to conventional dosage
forms for the purpose of colon targeting.
So, the present investigation was designed
to study pectin in combination of hydrox-
ypropylmethyl cellulose, hydroxyethyl
cellulose as a gelbased matrix systems for
colon drug targeting by using roentgeno-
graphic studies in healthy human volun-
teers by taking naproxen as a model drug.
MATERIALS AND METHODS:
1. Naproxen: Divi's Laboratories,
Hyderabad-India.
2. Pectin powder: Loba Chemicals Pvt.
Ltd., Mumbai-India.
3. Hydroxyethyl cellulose and hydroxy
propyl methyl cellulose: Himedia
Laboratories Ltd., Mumbai-India.
4. Ethylcellulose and cellulose acetate
phthalate: SD Fine Chemicals Pvt.,
Ltd., Mumbai-India
And other required laboratory chemi-
cals used are ofanalar grade.
Preparation of Matrix Tablets: The
formulation details and ingredients used
are shown in Table 1.
Matrix tablets containing each 150
mg ofnaproxen and 150 mg ofpectin were
prepared by conventional wet granulation
method using pectin alone and in combi-
nation with hydroxpropylmethyl cellulose
and hydroxyethyl cellulose was drug
Table 1. Formula and ingredients to prepare naproxen-pectin-based matrix tablets.
Formulations
Ingredients in mg/tab P1 Al A2 A3 Bi B2 B3
Naproxen 150 150 150 150 150 150 150
Pectin 150 150 150 150 150 150 150
Lactose 200 150 125 100 150 125 100
Hydroxy propyl methyl cellulose - 50 75 100
Hydroxy ethyl cellulose - - - 50 75 100
Total weight of the tablet (mg) 500 500 500 500 500 500 500
Each tablet contains 150 mg of the drug.
P1 = Plain naproxen-pectin tablet.
Al, A2, A3 = 10, 15, and 20 percent hydroxy propyl methyl cellulose naproxen-pectin tablet.







Figure 1. Comparative in vitro percent drug release of various uncoated naproxen-
pectin-based tablets.
regarding swelling gel systems using 10
percent starch paste as binder, talc 2 per-
cent, and mg stearate 2 percent as lubri-
cants. The tablet required amounts of lac-
tose as diluent. To cover all the variables,
seven different batches of formulations
were studied.
Preparation oftablets
The granules were compressed into
tablets of each 500 mg using 10 station
rotary tablet punching machine. The
tablets were compressed to a hardness of5
to 6 kg/cm2. Some selected formulations
were coated with 5 percent ethyl cellulose
and 5 percent cellulose acetate phthalate
solutions by pan-coating technique.
In vitro drug dissolution studies
The in vitro release of naproxen was
carried out by using dissolution test appa-
ratus ofUSP XXIII using 900 ml ofdisso-
lution fluid at varied pH dissolution media
of2 hours in 1.2 pH, 4hours in 4.5 pH and
2 hours in 7.4 pH buffer solution. The bas-
ket speed was adjusted at 50 ± 2 rpm at a
temperature of 37 ± 1°C. Five ml of
aliquote of samples were withdrawn at
each hourly interval and were replaced
with fresh dissolution fluid to maintain the
sink conditions. The samples withdrawn
were suitably diluted and absorbance was
measured at 261 nm in 1.2 pH, 269 nm in
4.5 pH, and 271 nm in 7.4 pH dissolution
media.
Drug content uniformity
Ten tablets from each formulation
were powdered, and a quantity equivalent
to 50 mg ofdrug content was dissolved in
100 ml of methanol and filtered. 10 ml of
filtrate was suitably diluted and analyzed
for drug content spectro-photometrically.
Roentgenographic studies
Ethical committee permission was
obtained for this study in consultation with
radiologist, using our teaching and general
hospital facilities. In these studies, nine
healthy male subjects in the age group of
20 to 25 years and having a body weight
between 50 to 65 kg participated in this
study without any prior medication. The
volunteers were divided into three groups
of each three members. The first group
was given plain uncoated tablets; the sec-
ond groups was given ethyl cellulose coat-
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Figure 2. In vitro drug release of HPMC 20 percent and HEC 20 percent naproxen-
pectin tablets coated with 5 percent ethylcellulose solution and 5 percent cellulose
acetate phthalate solution.
ethyl cellulose and cellulose acetate phtha-
late-coated tablets. The volunteers were
required to fast for at least 10 hours before
the study. The volunteers were given one
test tablet each followed by sufficient
water along with 200 ml of barium meal.
At different time intervals of 1, 3.5, 6, and
8 hours. The subjects were X-ray pho-
tographed to observe shape and integrity
and position of the tablet. The photograph
of X-ray studies revealed that the enteric
coated tablet was visible only up to 5.5
hours. At the end of eighth hour, the pho-
tograph has not shown any presence of
tablet.
Table 2. Comparative in vitro release naproxen from various uncoated matrix tables.
Percent naproxen released
Si. Time
no. (hr) P1 Al A2 A3 Bi B2 B3
1 0.5 1.20 1.00 1.50 1.20 1.08 1.20 0.90
2 1.0 1.50 6.00 5.40 3.60 1.50 1.50 1.08
3 2.0 6.00 10.00 16.50 15.00 8.40 3.00 1.50
4 3.0 15.00 32.58 34.50 28.50 9.90 3.30 3.30
5 4.0 92.50 37.08 40.50 31.50 11.40 3.90 4.50
6 5.0 100.01 82.50 66.00 36.90 34.50 11.50
7 6.0 100.50 85.50 51.90 47.40 35.10
8 7.0 - 100.30 68.40 59.40 45.00
9 8.0 - 84.90 72.90 63.00
Each tablet contains 150 mg of the drug.
P1 = Plain naproxen-pectin tablet.
Al, A2, A3 = 10, 15, and 20 percent hydroxy propyl methyl cellulose naproxen-pectin tablet.
Bi, B2, B3 = 10%, 15% and 20% hydroxy ethyl cellulose naproxen-pectin tablet.Rao et al: Naproxen-pectin-based matrix tablets forcolon 153
Table 3. In vitro drug release of Naproxen
from pectin, HPMC (20 percent) and HEC
(20 percent) combined matrixtablets coat-
ed with EC and CAR
Percent naproxen released
SI. Time
no. (hr) P1 Al A2
1 0.5 -
2 1.0
3 2.0 1.20 -
4 3.0 1.50 0.90
5 4.0 3.00 1.08 1.20
6 5.0 5.25 1.50 1.50
7 6.0 11.40 3.30 3.30
8 7.0 16.50 8.40 4.50
9 8.0 28.50 15.00 6.00
Each tablet contains 150 mg of the drug.
A3E: Naproxen-pectin tablets containing 20
percent Hydroxypropylmethyl cellulose coated
with 5 percent ethyl cellulose solution.
B3E: Naproxen-pectin tablets containing
Hydroxy ethyl cellulose 20 percent coated
with 5 percent ethyl cellulose solution.
B3C: Naproxen-pectin matrix tablet contain-
ing Hydroxy ethyl cellulose 20 percent coat-
ed with ethyl cellulose and 5 percent cellu-
lose acetate phthalate solution.
RESULTS AND DISCUSSION
The basic data of in vitro release of
naproxen for all the seven batches studied
are shown in Table 2 and Figure 1. The
result showed that plain naproxen, pectin
uncoated tablets gave complete release at
the end of fifth hour whereas pectin with
increased concentrations of hydroxy
propyl methyl cellulose (10, 15, 20percent
w/w) were found to be released complete-
ly by the end of6, 7, and 8 hours, whereas
the pectin-hydroxy ethyl cellulose system
was found to extend the release even after
the eighth hour, at the end of which an
amount of 84.9 percent, 72.9 percent, and
63.0 percent of drug was found to be
released from these uncoated tablet formu-
lations. So, these formulations were fur-
ther coated with 5 percent ethyl cellulose
and 5 percent cellulose acetate phthalate
solutions to control the drug release up to
6 hours. The results indicated that, after 8
hours release study, 8.4 percent drug
release from ethyl cellulose coating and 4
percent drug release from ethyl cellulose
and cellulose acetate phthalate coatings
from 20 percent hydroxy ethyl cellulose
matrix tablets. The results showed that the
uncoated tablet systems are not suitable to
be used as colon targeted drug delivery
systems. The aim ofthe present work is to
achieve the disintegration of the tablet
only after reaching colon. From these
studies, it can be presumed that the ethyl
cellulose and cellulose acetate phthalate
coated (Table 3, Figure 2) tablet after
reaching colon at the end of 7.5 hours
might have degraded by the resident
anaerobic microflora present in the colon
of human volunteers. So the results of
roentgenographic studies clearly revealed
the transit of the selected matrix tablet up
to the colon. The disappearance of the
tablet in colon region as shown in photo-
graph has revealed unambiguous evidence
for the degradation of the tablet in the
colon, which can be considered as a sig-
nificant finding for the utilization of
pectin, hydroxy ethyl cellulose system
with ethyl cellulose, cellulose acetate
phthalate coatings as a potential carrier for
the delivery ofthe drug at the specific tar-
geted site ofcolon.
DISCUSSION
Among the two selected hydrocol-
loids, hydroxy propyl methyl cellulose due
to its high hydrophilicity was found to be
inferior to hydroxy ethyl cellulose in
achieving colon-targeted drug delivery.
So, the results have conclusively proved
that addition of hydroxy ethyl cellulose
(20 percent w/w) along with pectin coated
with ethyl cellulose and cellulose acetate
phthalate will be an ideal carrier for colon
targeted drug delivery.154 Rao et al: Naproxen-pectin-based matrix tablets for colon
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